First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 studyArjun Vasant Balar, Joaquim Bellmunt, Noah M. Hahn et al.|The Lancet Oncology|2017Cited by 1.3k
Long-Term Outcomes in KEYNOTE-052: Phase II Study Investigating First-Line Pembrolizumab in Cisplatin-Ineligible Patients With Locally Advanced or Metastatic Urothelial CancerJacqueline Vuky, Elizabeth R. Plimack, Arjun Vasant Balar et al.|Journal of Clinical Oncology|2020Cited by 292
Activation of c-Jun N-Terminal Kinase and p38 in an Alzheimer's Disease Model Is Associated with Amyloid DepositionMary J. Savage, Richard W. Scott|Journal of Neuroscience|2002Cited by 289
CNS Amyloid- , Soluble APP- and - Kinetics during BACE InhibitionRandall J. Bateman, Maria S. Michener, Guoxin Wu et al.|Journal of Neuroscience|2014Cited by 40